Literature DB >> 20157762

HGF upregulates CXCR4 expression in gliomas via NF-kappaB: implications for glioma cell migration.

Mine Esencay1, Elizabeth W Newcomb, David Zagzag.   

Abstract

Invasion is a hallmark of malignant gliomas and is the main reason for therapeutic failure and recurrence of the tumor. CXCR4 is a key chemokine receptor implicated in glioma cell migration whose expression is regulated by hypoxia. Here, we report that hepatocyte growth factor (HGF) upregulated CXCR4 protein expression in glioma cells. HGF pre-treatment increased migration of U87MG and LN229 glioma cells towards the CXCR4 ligand, stromal cell-derived factor-1alpha (SDF-1alpha). AMD3100, a CXCR4 inhibitor, inhibited the increased migration of HGF pre-treated LN229 glioma cells towards SDF-1alpha. Following exposure to HGF and hypoxia, both cell lines showed nuclear translocation of NF-kappaB (p65). The HGF- and hypoxia-induced nuclear translocation of NF-kappaB (p65) involved phosphorylation and degradation of IkappaB-alpha. Knock-down of NF-kappaB expression inhibited the induction of CXCR4 expression in response to HGF, but not to hypoxia. However, knock-down of NF-kappaB expression inhibited the induction of CXCR4 expression in response to hypoxia in the presence of HGF. NF-kappaB mediated migration towards SDF-1alpha in response to HGF. Knock-down of NF-kappaB expression resulted in decreased migration of HGF pre-treated glioma cells towards SDF-1alpha. Therefore, HGF upregulates CXCR4 expression via NF-kappaB and leads to enhanced migration. To our knowledge, this is the first report to show that a crosstalk mediated by NF-kappaB exists between the SDF-1alpha/CXCR4 and HGF/c-Met axes relevant to glioma cell migration. These findings imply that effective inhibition of glioma invasion should be directed against several ligand/receptor signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20157762      PMCID: PMC3767998          DOI: 10.1007/s11060-010-0111-2

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  35 in total

1.  Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma.

Authors:  S A Rempel; S Dudas; S Ge; J A Gutiérrez
Journal:  Clin Cancer Res       Date:  2000-01       Impact factor: 12.531

Review 2.  Regulation of the transcriptional activity of the nuclear factor-kappaB p65 subunit.

Authors:  Linda Vermeulen; Gert De Wilde; Sofie Notebaert; Wim Vanden Berghe; Guy Haegeman
Journal:  Biochem Pharmacol       Date:  2002-09       Impact factor: 5.858

3.  Expression and localization of scatter factor/hepatocyte growth factor in human astrocytomas.

Authors:  P Kunkel; S Müller; P Schirmacher; D Stavrou; R Fillbrandt; M Westphal; K Lamszus
Journal:  Neuro Oncol       Date:  2001-04       Impact factor: 12.300

4.  Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer.

Authors:  Chris J Scotton; Julia L Wilson; Kate Scott; Gordon Stamp; George D Wilbanks; Simon Fricker; Gary Bridger; Frances R Balkwill
Journal:  Cancer Res       Date:  2002-10-15       Impact factor: 12.701

5.  CXCR4 is a major chemokine receptor on glioma cells and mediates their survival.

Authors:  Yan Zhou; Peter H Larsen; Chunhai Hao; V Wee Yong
Journal:  J Biol Chem       Date:  2002-10-17       Impact factor: 5.157

6.  Potentiation of invasive activity of hepatoma cells by reactive oxygen species is mediated by autocrine/paracrine loop of hepatocyte growth factor.

Authors:  Yutaka Miura; Yasuhiro Kozuki; Kazumi Yagasaki
Journal:  Biochem Biophys Res Commun       Date:  2003-05-23       Impact factor: 3.575

7.  Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene.

Authors:  Selma Pennacchietti; Paolo Michieli; Maria Galluzzo; Massimiliano Mazzone; Silvia Giordano; Paolo M Comoglio
Journal:  Cancer Cell       Date:  2003-04       Impact factor: 31.743

Review 8.  Cost of migration: invasion of malignant gliomas and implications for treatment.

Authors:  A Giese; R Bjerkvig; M E Berens; M Westphal
Journal:  J Clin Oncol       Date:  2003-04-15       Impact factor: 44.544

9.  Glioblastoma and cerebral microvascular endothelial cell migration in response to tumor-associated growth factors.

Authors:  Marc-Alexander Brockmann; Ulrike Ulbricht; Katrin Grüner; Regina Fillbrandt; Manfred Westphal; Katrin Lamszus
Journal:  Neurosurgery       Date:  2003-06       Impact factor: 4.654

10.  Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis.

Authors:  Judong Pan; Javier Mestas; Marie D Burdick; Roderick J Phillips; George V Thomas; Karen Reckamp; John A Belperio; Robert M Strieter
Journal:  Mol Cancer       Date:  2006-11-03       Impact factor: 27.401

View more
  29 in total

Review 1.  The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma.

Authors:  Alphonse E Sirica
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-11-29       Impact factor: 46.802

Review 2.  Migration and fate of therapeutic stem cells in different brain disease models.

Authors:  B J Carney; K Shah
Journal:  Neuroscience       Date:  2011-09-14       Impact factor: 3.590

3.  A functional polymorphism in the pre-miR-146a gene is associated with risk and prognosis in adult glioma.

Authors:  Jennifer Permuth-Wey; Reid C Thompson; L Burton Nabors; Jeffrey J Olson; James E Browning; Melissa H Madden; Y Ann Chen; Kathleen M Egan
Journal:  J Neurooncol       Date:  2011-07-09       Impact factor: 4.130

Review 4.  Targeting CXCL12/CXCR4 Axis in Tumor Immunotherapy.

Authors:  Weiqiang Zhou; Shanchun Guo; Mingli Liu; Matthew E Burow; Guangdi Wang
Journal:  Curr Med Chem       Date:  2019       Impact factor: 4.530

Review 5.  The intricate role of CXCR4 in cancer.

Authors:  Samit Chatterjee; Babak Behnam Azad; Sridhar Nimmagadda
Journal:  Adv Cancer Res       Date:  2014       Impact factor: 6.242

Review 6.  Stem cell-based therapies for tumors in the brain: are we there yet?

Authors:  Khalid Shah
Journal:  Neuro Oncol       Date:  2016-06-09       Impact factor: 12.300

7.  Novel organotypic culture model of cholangiocarcinoma progression.

Authors:  Deanna J W Campbell; Catherine I Dumur; Nadia F Lamour; Jennifer L Dewitt; Alphonse E Sirica
Journal:  Hepatol Res       Date:  2012-05-09       Impact factor: 4.288

8.  AXL and MET crosstalk to promote gonadotropin releasing hormone (GnRH) neuronal cell migration and survival.

Authors:  Smita Salian-Mehta; Mei Xu; Margaret E Wierman
Journal:  Mol Cell Endocrinol       Date:  2013-05-03       Impact factor: 4.102

9.  VEGFR inhibitors upregulate CXCR4 in VEGF receptor-expressing glioblastoma in a TGFβR signaling-dependent manner.

Authors:  Kien Pham; Defang Luo; Dietmar W Siemann; Brian K Law; Brent A Reynolds; Parvinder Hothi; Gregory Foltz; Jeffrey K Harrison
Journal:  Cancer Lett       Date:  2015-02-09       Impact factor: 8.679

10.  Nix protein positively regulates NF-κB activation in gliomas.

Authors:  Yuntao Lu; Leyu Wang; Minyi He; Wenhua Huang; Hong Li; Yongkui Wang; Jiming Kong; Songtao Qi; Jun Ouyang; Xiaozhong Qiu
Journal:  PLoS One       Date:  2012-09-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.